• NSW Cancer Research Education SSS May 2024

    Educational Molecular Tumour Board.The potential role of precision medicine in altering the poor outcomes in pancreas cancer.Pancreatic cancer has a poor prognosis and an urgent need for new effective treatments. In this educational Molecular Tumour Board session, we will hear an update on the molecular features of pancreatic cancer and their relevance to clinical management. … Read more

  • NSW Cancer Research Education SSS April 2024

    Liquid Biopsy in CancerLiquid biopsies of blood, urine, or other body fluid such as ascites are gaining interest in cancer diagnostics and treatment. In this session Professor Helen Rizos will discuss liquid biopsies in melanoma – how they can monitor response, predict patient outcomes and current limitations in the application of liquid biopsies and Dr … Read more

  • NSW Cancer Research Education SSS March 2024

    Familial Cancer Syndromes and their Clinical ManagementThis webinar draws together interdisciplinary experts to focus on “Familial Cancer Syndromes and Clinical Management”, specifically to increase our understanding of inherited cancer risks and their clinical management skills. Our invited speakers will share insights into the research around the genetic basis of inherited cancer syndromes, including familial breast … Read more

  • NSW Cancer Research Education SSS. February 2024

    Treatment-induced DNA methylation heterogeneity and implications for cell growth in Acute Myeloid Leukaemia This session will focus on hypomethylating agents (HMAs), which are used to treat people living with acute myeloid leukaemia (AML) and myelodysplasia. While these epigenetic therapies extend survival in many patients, low response rates and therapy-resistant relapse remain significant challenges. Relapse is … Read more

  • NSW Cancer Research Education SSS. November 2023

    Enhancing HCC Surveillance: A Deep Dive into the Australian Clinical Practice GuidelinesIn this session discover the groundbreaking Clinical Practice Guidelines for Hepatocellular Carcinoma (HCC)surveillance in Australia. Developed alongside a diverse, multi-disciplinary team, these guidelines provide evidence-based recommendations to guide HCC surveillance for individuals at high risk. Don’t miss this opportunity to delve into the world … Read more

  • NSW Cancer Research Education SSS. October 2023

    Educational Molecular Tumour BoardMelanoma Institute Australia – Personalised Immunotherapy ProgramPlease join us for this Educational Molecular Tumour Board Session with presenters from the Melanoma Institute Australia giving insight into their Personalised Immunotherapy Program. This presentation will cover:– The background around genomic, transcriptomic and tumour immune profiling as biomarkers of response to immunotherapies.– Biomarker multidisciplinary discussion … Read more

  • NSW Cancer Research Education SSS. August 2023

    “Burning Issues in Radiotherapy Research”This session will provide a great opportunity to explore radiation oncology as a vibrant research sphere that researchers may never have considered before. Hear about the consumer experience, the role of biology in radiation research, the examination of technology and the role of radiation oncology clinical trials. SpeakersAssociate Professor Eric Hau. Radiation … Read more

  • NSW Cancer Research Education SSS. July 2023

    “Preventing cardiovascular morbidity and mortality in cancer patients”Currently, there are over 30 million cancer survivors worldwide. Cancer survivorship is expected to grow by 30%, and it is estimated that about 2 million Australians by 2040 will be living beyond cancer. This is due to improvements in cancer screening, effective treatments and the aging of the … Read more

  • NSW Cancer Research Education SSS. June 2023

    “The gut microbiome and neo-adjuvant immunotherapy: implications for efficacy and toxicity.”Immune checkpoint inhibitor (ICI) immunotherapies have revolutionised the treatment of melanoma, although drug resistance or concurrent immune-related adverse events (irAEs) still impact many patients. In this session the influence of the gut microbiome on clinical outcomes will be discussed using a large clinical trial cohort … Read more

  • NSW Cancer Research Education SSS. May 2023

    Session InformationThe PREDICT program, funded by Cancer Council NSW, aims to develop a personalised chemotherapy dosing system for cancer patients to improve quality of life, reduce side effects and increase chance of survival. Current chemotherapy dosing is imprecise and not personalised. It is estimated that 20-30% of patients receiving chemotherapy will receive a dose that … Read more